Category: Compliance Monitoring

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

Leveraging Aggregate Spend Data in Life Sciences: Uncover Competitive Insights

Annual transparency reports or aggregate spending reporting have become an integral part of life science organizations. But where the submission of such reports is imperative, it can be challenging to sort tangled data, let alone validate it or structure it. Still, countless life science companies have managed to make their aggregate spend data publicly available. […]

Navigating the Key Shift in PhRMA Code

The biggest change to the PhRMA Code is a change that has now been added to Section 2, which is the section on informational programs with meals that reps have in the regular course of their day-to-day activities. The revised Code adds the following language to Section 2: “Incidental meals can be provided only where […]

CMS Requirements for Life Sciences Companies in 2022

Starting off 2022, CMS has issued new updates in the Open Payments program that will be effective for data collection beginning in Calendar Year 2023 and applicable to data reported in Calendar Year 2024. In the Calendar Year 2022, CMS has finalized the proposed changes to the Open Payments program to ensure adequate usability and […]

3 Key Strategies for Effective Risk-Based Monitoring

Having a compliance program that ensures 100% adherence to regulations is realistically not possible. But there are monitoring practices that can help you go closer to that ideal. Over the years, compliance monitoring has transformed. Compliance professionals across the industry are now working round the clock to make sure their HCP interactions are by the […]

Quick Review of PhRMA Code Updates and Implications in 2022

As the New Year 2022 begins, a lot of compliance professionals might also be making new year resolutions about being more diligent with their monitoring. Here’s a quick recap of the PhRMA Code that recently got updated in the wake of OIG’s Special Fraud Alert for Speaker Programs. The Seven Principles of Speaker Programs The […]

FAQs on PhRMA Code Update: How Does It Apply to Me?

qordata hosted a webinar with Seth Lundy and Brian Bohnenkamp from King & Spalding to keep the compliance community updated with recent changes in PhRMA Code and the implications on life sciences compliance after those revisions. A number of questions were raised in our webinar that Seth and Brian tried to answer. Here’s a summary […]